...Health info at your doorstep

Day: 11 September 2020

Africa Launches ‘Genome’ Laboratories for COVID-19

Africa Launches ‘Genome’ Laboratories for COVID-19

Coronavirus, NEWS
The World Health Organisation and the Africa Centres for Disease Control and Prevention on Thursday launched a network of laboratories to reinforce genome sequencing of the virus that causes COVID-19. WHO Regional Director for Africa, Matshidiso Moeti, disclosed this in Cape Town, South Africa. Twelve reference laboratories in various African countries will provide sequencing, data analysis and technical support services to the rest of the continent, the two organisations announced in a joint statement. “As we continue to tackle the COVID-19 pandemic in Africa, being able to not only track its evolution but also assess the possible mutation of the virus is crucial to mounting an effective response,” said Moeti. The laboratory network will also inform the development
95% of World Population Still at Risk of COVID-19 –EU Commission

95% of World Population Still at Risk of COVID-19 –EU Commission

Coronavirus, NEWS
The European Commission said on Thursday that up to 95 per cent of the world’s population was still at risk of the coronavirus, particularly in developing countries. President of the commission Ursula von der Leyen said this at the first Access to COVID-19 Tools Accelerator Facilitation Council meeting. “We have seen that the virus does not respect borders or conventions. “We are all affected. Globally up to 95 per cent of the population is still at risk and developing countries are particularly vulnerable. “But also industrialised countries are not safe. “And if we wanted an experience of what it means that ‘no one is safe until everyone is safe’ there is probably no tougher lesson to be learned as from this pandemic,” von der Leyen said. UN Secretary-General
Oxford COVID-19 Vaccine Still Possible this Year, Despite Trial Pause ­­–AstraZeneca

Oxford COVID-19 Vaccine Still Possible this Year, Despite Trial Pause ­­–AstraZeneca

Coronavirus, NEWS
Drug manufacturing company, AstraZeneca, on Thursday said the COVID-19 vaccine the company is working on could still be available at the end of the year, despite a pause in the Oxford University randomized clinical trial. “We could still have a vaccine by the end of this year, early next year,” the UK-based company’s Chief Executive Pascal Soriot said in comments at a media event. AstraZeneca had announced on Wednesday that it had “voluntarily paused” its trial of a drug developed alongside Oxford University after a UK volunteer developed an unexplained illness. An independent committee was drafted in to review safety but the company said it was a “routine action” designed to maintain the integrity of the trials. “We will be guided by this committee as to when the t